Multiple endocrine neoplasia type 2. Clinical features and screening.

scientific article published on March 1994

Multiple endocrine neoplasia type 2. Clinical features and screening. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0889-8529(18)30121-X
P698PubMed publication ID7913021

P2093author name stringGrauer A
Raue F
Frank-Raue K
P2860cites workA REVIEW OF 17 CASES OF CARCINOMA OF THE THYROID AND PHAEOCHROMOCYTOMAQ24561690
Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinomaQ30411356
Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen's diseaseQ34224725
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.Q34334980
Early diagnosis of the multiple endocrine neoplasia type 2 syndrome: consensus statement. European Community Concerted Action: Medullary Thyroid CarcinomaQ35275653
Incidence of sporadic and familial medullary thyroid carcinoma in Sweden 1959 through 1981. A nationwide study in 126 patients. Swedish MCT Study GroupQ38056139
Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasmQ38520681
Advances in the diagnosis and treatment of medullary thyroid carcinoma.Q39462141
C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2BQ39824843
Current concepts. Pheochromocytoma: diagnosis, localization and managementQ40095614
Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursorsQ41059646
Multiple Endocrine Neoplasia Type IIb: The Most Aggressive Form of Medullary Thyroid CarcinomaQ41591754
Importance of early diagnosis and follow-up in multiple endocrine neoplasia (MEN II B).Q42248203
Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2aQ42445792
Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia, type 2Q72424148
Medullary (solid) carcinoma of the thyroid; a clinicopathologic entityQ78516362
Familial endocrine tumors; report of two unrelated kindred affected with pheochromocytomas, one also with multiple thyroid carcinomasQ79373120
Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinomaQ42453110
Chromogranin A as tumor marker in medullary thyroid carcinomaQ42453379
Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinomaQ42460217
Multiple endocrine syndrome type IIb in early childhoodQ42473107
Results of a screening program for C-cell disease (medullary thyroid cancer and C-cell hyperplasia).Q42483809
Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.Q42485855
Somatostatin in medullary thyroid cancer. In vitro and in vivo studies.Q42494558
Hereditary localized pruritus in affected members of a kindred with multiple endocrine neoplasia type 2A (Sipple's syndrome).Q42494889
Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screeningQ42495031
Medullary carcinoma in children. Results of early detection and surgeryQ42498682
Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serumQ42527568
Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapyQ44737758
Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative GroupQ44951307
Multiple endocrine neoplasia IIb: an unusual cause of chronic constipationQ45048569
Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysisQ46812588
A kindred with multiple endocrine neoplasia type 2A associated with pruritic skin lesionsQ46955094
Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroidQ48019135
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.Q48114164
The occurrence of multiple endocrine neoplasia type IIb, in two children of an affected mother.Q51789075
Cushing's syndrome caused by ACTH- and calcitonin-secreting medullary carcinoma of the thyroid.Q53839590
A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10Q55670968
The association of pheochromocytoma with carcinoma of the thyroid glandQ56211630
Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkageQ57319205
The Natural Course of Multiple Endocrine Neoplasia Type iibQ62978399
Multiple endocrine neoplasia syndrome type 2: The value of screening and central registrationQ62978432
Medullary carcinoma of the thyroid glandQ66908748
Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970Q67582013
Epidemiology of medullary carcinoma of the thyroid gland: a 5-year experience (1971-1976)Q67664931
Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patientsQ67936617
Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2Q68729988
[Katacalcin--a new tumor marker in C-cell cancer of the thyroid gland]Q68945338
Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA contentQ69015456
Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphyQ69247020
Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981Q69367581
Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosisQ69376131
Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conferenceQ69383028
Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomyQ69771884
Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2Q69891636
Risk estimation and screening in families of patients with medullary thyroid carcinomaQ69912692
The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experienceQ69912831
C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumorsQ69922188
The importance of early diagnosis in patients with hereditary medullary thyroid carcinomaQ70329549
Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin AssayQ70537361
Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome)Q70782484
Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidineQ70783989
Familial medullary thyroid carcinoma and C cell hyperplasiaQ70938789
Medullary thyroid carcinoma: prognostic factors and treatmentQ71687294
Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma RegisterQ72213388
P433issue1
P921main subjectmultiple endocrine neoplasiaQ1553018
P304page(s)137-156
P577publication date1994-03-01
P1433published inEndocrinology and Metabolism Clinics of North AmericaQ15763298
P1476titleMultiple endocrine neoplasia type 2. Clinical features and screening
P478volume23

Reverse relations

cites work (P2860)
Q74127799A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma
Q36722002Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey
Q37785239Endocrine Cancer Predisposition Syndromes: Hereditary Paraganglioma, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2, and Hereditary Thyroid Cancer
Q40975238Evaluation and management of the solid thyroid nodule.
Q33706700Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study
Q35692908Hyperaldosteronism and pheochromocytoma: new tricks and tests
Q36179244Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes.
Q74453797Molecular Screening for RET Proto-Oncogene Mutations in a German MEN2A Pedigree
Q83912480Multiple endocrine neoplasia 2B presenting with pseudo-Hirschsprung's disease
Q46795959Multiple endocrine neoplasia type 2A/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma
Q34253160Multiple endocrine neoplasia type 2B--genetic basis and clinical expression
Q34209934Old and new insights in the treatment of thyroid carcinoma.
Q84961635Pheochromocytoma: diagnostic and therapeutic update
Q38614500Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.
Q42524637Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center
Q44035070Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study
Q79448269Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients
Q74454035Simultaneous medullary and papillary microcarcinoma of thyroid in a patient with secondary hyperparathyroidism
Q77735581Surgery for Hyperparathyroidism
Q33587939The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2
Q41202108Thyroid cancer in children, pregnant women, and patients with Graves' disease
Q37678245Update multiple endocrine neoplasia type 2.
Q85653523[Endocrine tumors: clinical overview]

Search more.